Lilly
-
NEWS & UPDATES
World Diabetes Day
November 14, 2025 “Despite advances in prevention, management and care, diabetes continues to pose immense challenges for people and healthcare…
Read More » -
NEWS & UPDATES
Reducing obesity can reshape the KSA society
A new Study Uncovers Unprecedented Socioeconomic Benefits of Obesity Treatment in Saudi Arabia Accelerating obesity treatment in Saudi Arabia could…
Read More » -
NEWS & UPDATES
Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and asafety profile consistent with injectable GLP-1 medicines, incomplete Phase 3 results
The investigational once-daily pill lowered A1C by an average of 1.3% to 1.6% across doses, with improvements seen as early…
Read More »